Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Thromboelastographic and hemostatic characteristics in pediatric patients with sickle cell disease.

Yee DL, Edwards RM, Mueller BU, Teruya J.

Arch Pathol Lab Med. 2005 Jun;129(6):760-5.

PMID:
15913424
2.

Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.

Brown AK, Sleeper LA, Miller ST, Pegelow CH, Gill FM, Waclawiw MA.

Arch Pediatr Adolesc Med. 1994 Aug;148(8):796-804.

PMID:
7519102
3.

Pitted red cell counts in sickle cell disease. Relationship to age, hemoglobin genotype, and splenic size.

Fatunde OJ, Scott RB.

Am J Pediatr Hematol Oncol. 1986 Winter;8(4):329-33.

PMID:
3799933
4.

Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?

Segel GB, Simon W, Lichtman MA.

Pediatr Blood Cancer. 2011 Jul 15;57(1):8-9. doi: 10.1002/pbc.23128. Epub 2011 Apr 7. No abstract available.

PMID:
21480473
5.

Sickle cell syndromes. II. The sickle cell anemia-alpha-thalassemia syndrome.

Honig GR, Koshy M, Mason RG, Vida LN.

J Pediatr. 1978 Apr;92(4):556-61.

PMID:
633012
6.

The red cell distribution width in sickle cell disease--is it of clinical value?

Thame M, Grandison Y, Mason K, Thompson M, Higgs D, Morris J, Serjeant B, Serjeant G.

Clin Lab Haematol. 1991;13(3):229-37.

PMID:
1794225
7.

Irreversibly sickled cells and splenomegaly in sickle-cell anaemia.

Serjeant GR.

Br J Haematol. 1970 Nov;19(5):635-41. No abstract available.

PMID:
5481507
8.

Diagnostic value of anemia, red blood cell morphology, and reticulocyte count for sickle cell disease.

Losek JD, Hellmich TR, Hoffman GM.

Ann Emerg Med. 1992 Aug;21(8):915-8.

PMID:
1497156
9.

On the levels of hemoglobins F and A2 in sickle-cell anemia and some related disorders.

Wrightstone RN, Huisman TH.

Am J Clin Pathol. 1974 Mar;61(3):375-81. No abstract available.

PMID:
4205296
10.

Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia.

Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A.

J Lab Clin Med. 1997 May;129(5):507-16.

PMID:
9142047
11.

Survival analysis by sex, age group and hemotype in sickle cell disease.

Murthy VK, Haywood LJ.

J Chronic Dis. 1981;34(7):313-9. No abstract available.

PMID:
7251812
12.

A comparison of erythrocyte characteristics in sickle cell syndromes in Jamaica.

Serjeant GR, Serjeant BE.

Br J Haematol. 1972 Aug;23(2):205-13. No abstract available.

PMID:
5070127
14.

Pathophysiology and treatment of sickle cell disease.

Raphael RI.

Clin Adv Hematol Oncol. 2005 Jun;3(6):492-505. Review.

PMID:
16167028
15.

Red cell profile in normal and sickle cell diseased children.

el Sayed HL, Tawfik ZM.

J Egypt Soc Parasitol. 1994 Apr;24(1):147-54.

PMID:
8169436
16.

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.

Medicine (Baltimore). 1996 Nov;75(6):300-26.

17.

Density distribution of red cells and prognostic significance in 50 patients with homozygous sickle-cell disease.

Pajot N, Maier-Redelsperger M, Dode C, Labie D, Girot R.

Haematologia (Budap). 1988;21(4):189-97.

PMID:
3209123
18.

Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease.

Amin MA, Amin AP, Kulkarni HR.

Ann Hematol. 2004 Jun;83(6):331-5. Epub 2004 Mar 30.

PMID:
15052371
20.

Effect of alpha thalassaemia on the rheology of homozygous sickle cell disease.

Serjeant BE, Mason KP, Kenny MW, Stuart J, Higgs DR, Weatherall DJ, Hayes RJ, Serjeant GR.

Br J Haematol. 1983 Nov;55(3):479-86.

PMID:
6639889

Supplemental Content

Support Center